Which has grown faster, BIO or IBRX?

Over the past five years, IBRX grew revenue faster — BIO at a 0.29% CAGR versus IBRX at 202.97%.

Is BIO or IBRX more profitable?

BIO runs the higher net margin — BIO at 8.59% versus IBRX at -598.56%.

How have BIO and IBRX total returns compared?

Over the past 10 years, BIO delivered 8.63% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs ImmunityBio, Inc. (IBRX)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$9.93B

$368.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

IBRX

ImmunityBio, Inc.

$10.15B

$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BIO vs IBRX

growth of $100 · dividends reinvested · last 10y

BIO +134.3% (+8.9%/yr)IBRX +41.8% (+3.6%/yr)BIO compounded faster over this window

BIO IBRX

BIO vs IBRX: by the numbers

•IBRX is the larger company ($10.15B vs $9.93B market cap).
•BIO is profitable (8.59% net margin) while IBRX runs a net loss (-598.56%).
•IBRX grew revenue faster over the past five years (202.97% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	IBRX
P/E ratio	44.71	N/A
Forward P/E	37.84	N/A
P/S ratio	3.83	61.21
P/B ratio	1.38	N/A
EV / EBITDA	27.75	N/A
FCF yield	3.56%	N/A

Profitability

Metric	BIO	IBRX
Gross margin	51.90%	94.63%
Operating margin	9.08%	-226.00%
Net margin	8.59%	-598.56%
ROE	3.10%	N/A
ROIC	1.54%	-45.63%

Growth (annualized)

Metric	BIO	IBRX
Revenue CAGR (5Y)	0.29%	202.97%
EPS CAGR (5Y)	-26.27%	N/A
FCF CAGR (5Y)	-9.65%	N/A
Total return CAGR (5Y)	-12.59%	0.39%

Frequently asked

Which has grown faster, BIO or IBRX?: Over the past five years, IBRX grew revenue faster — BIO at a 0.29% CAGR versus IBRX at 202.97%.
Is BIO or IBRX more profitable?: BIO runs the higher net margin — BIO at 8.59% versus IBRX at -598.56%.
How have BIO and IBRX total returns compared?: Over the past 10 years, BIO delivered 8.63% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full IBRX analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Bio-Rad Laboratories ROE ImmunityBio ROE Bio-Rad Laboratories operating margin ImmunityBio operating margin Bio-Rad Laboratories revenue growth ImmunityBio revenue growth Bio-Rad Laboratories free cash flow ImmunityBio free cash flow

Bio-Rad Laboratories & ImmunityBio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.